The Congressional Budget Office projects that drug pricing measures in Democrats’ Build Back Better bill, including savings and new revenues, would reduce the deficit by $297 billion and would result in 10 fewer drug inventions out of the 1,300 drugs expected to be introduced in the next 30 years. The scaled-back Medicare price negotiation piece of that accounts for $79 billion in savings, which is far less than the other drug pricing measures. House Democratic leadership’s original Medicare drug negotiation...